null

Assistant Professor Wee Hwee Lin

BSc (Pharm) (Hons), National University of Singapore
PhD, National University of Singapore

Department of Pharmacy, National University of Singapore
18 Science Drive 4, Singapore 117543
Tel: +65 6516 5530
Fax: +65 6779 1554
Email: phawhl@nus.edu.sg

Research Focus

Pharmacoeconomics and Outcome Research, in particular, cost-effectiveness analysis of pharmaceuticals, pharmacogenetic tests and health services in the areas of Type 2 diabetes mellitus, colorectal cancer and breast cancer.

Awards (Post-PhD)

  • UK-Singapore Partners in Science Collaboration Award, 2012
  • International Society for Quality of Life Research New Investigator Award (Poster Category), 2011

World Health Organization Quality of Life Questionnaire: Deriving Population Normative Data and Mapping to Legacy HEalth-Related Quality of Life Questionnaires for use in Singapore (WONDERS)

Sponsor: Ministry of Health Health Services Research Competitive Research Grant
Total project value: $571,214

Planned manuscripts:
1. Reliability and validity of the WHOQOL-BREF for the Singapore population
2. Normative data for the WHOQOL-BREF for the Singapore population
3. Mapping of WHOQOL-BREF to EQ-5D-5L Utilities

 

Factors associated with Glycaemic Control Trajectories in Type 2 Diabetes

Sponsor: Ministry of Education Academic Research Fund Tier 1
Total Project Value: $159,998

Planned manuscripts:
1. Factors associated with Glycaemic Control Trajectories in Type 2 Diabetes

  1. Mean Rank, Equipercentile and Regression Mapping of World Health Organization Quality of Life Brief (WHOQOL-BREF) to EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) Utilities
  2. Reliability and Validity of the English, Chinese and Malay language versions of the WHOQOL-BREF in Singapore

Current:

  • Ms. Wang Wei, Vivian, submitted Mar 2016
    Thesis title: Economic and humanistic burden of dementia in Singapore
  • Miss Soon Swee Sung, commenced Aug 2012
    Thesis title: Repurposing Aspirin – Its Role in Chemoprevention of Colorectal Cancer
  • Mr Mcvin Cheen Hua Heng (Part-time), commenced Jan 2013
    Thesis title: Evaluating the outcomes of pharmacist-provided medication review and ambulatory care services in Singapore
  • Mr Casper Keegan Lin Rongrui (Part-time), commenced Jan 2014
    Thesis title: Oncology patients’ beliefs in therapy and supportive care and their adherence
  • Miss Wong Xinyi, commenced Aug 2015
    Thesis title: Patient preferences for cancer screening and treatments

Graduated: 

  • Dr Gan Hua Pey, conferred 2014
    Thesis title: Developing workplace-based smoking cessation programme in Sinagpore.
Co-supervisor: Professor Li Shu Chuen, Visiting Professor, Department of Pharmacy, NUS
  • Dr Ow Yen Ling Mandy, conferred 2012
    Thesis title: Assessing Health-Related Quality of Life and the Economic Cost of Systemic Lupus Erythematosus in Singapore.
    Co-supervisors: A/P Julian Thumboo, Senior Consultant and Head, Department of Rheumatology & Immunology, Singapore General Hospital; Professor Li Shu Chuen, Visiting Professor, Department of Pharmacy, NUS
  • Dr Zhao Yingjiao, conferred 2010
    Thesis title: Pharmacoeconomics and Health Outcomes Research Amongst Asian Parkinson’s Disease Patients in Singapore.
    Co-supervisors: Professor Li Shu Chuen, Visiting Professor, Department of Pharmacy, NUS; Dr Luo Nan, Assistant Professor, Department of Epidemiology & Public Health, NUS.
  • Dr Tipaporn Pongmesa, conferred 2010
    Thesis title: Management of Diabetes Mellitus in Asia: A comparison between Thailand and Singapore.
    Co-supervisor: Professor Li Shu Chuen, Visiting Professor, Department of Pharmacy, NUS.
  • Novartis Asia Pacific Pharmaceuticals Pte Ltd
  • AbbVie Ptd Ltd
  • Pfizer Pte Ltd
  • National Healthcare Group, Singapore
  • Singapore Health Services

Fun and enriching experience as moderator and speaker at a forum entitled “Use and Management of Big Data in Health Economics and Outcomes Research for Creating Best Practices in Asia-Pacific: Experiences and Lessons Learned In Australia, Japan, Singapore, South Korea, and Taiwan“, which was held at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting in Washington DC, 21-25 May 2016.

whl_ispor-short-course-overview

 

whl_ispor_speaker